Clara Clipet-Jensen1, Andreas Andersen1, Aksel Karl Georg Jensen1,2, Peter Aaby1,3, K Zaman4. 1. Research Centre for Vitamins and Vaccines (CVIVA), Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark. 2. Section of Biostatistics, University of Copenhagen, Denmark. 3. Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau. 4. International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Abstract
BACKGROUND: Due to delays in vaccinations, diphtheria-tetanus-whole-cell-pertussis (DTP) is often given with or after measles vaccine (MV)-out of sequence. We reanalyzed data from Matlab, Bangladesh, to examine how administration of MV and DTP out-of-sequence was associated with child survival. METHODS: In sum, 36 650 children born between 1986 and 1999 were followed with registration of vaccinations and survival. Controlling for background factors using Cox proportional hazards models, survival was analyzed between 9 and 24 months of age. We measured the mortality rate ratio (MRR) to compare vaccination groups. Oral polio vaccine (OPV) campaigns, which started in 1995, reduced the mortality rate and reduced the difference between vaccination groups. In the main analysis, we therefore censored for OPV campaigns; there were 151 nonaccident deaths before the OPV campaigns. RESULTS: Compared with MV administered alone (MV-only), DTP administered with or after MV had MRR 2.20 (1.31-3.70), and DTP-only had MRR 1.78 (1.01-3.11). Compared with MV-only, DTP administered with MV had a female-male MRR 0.56 (0.13-2.38), significantly different to DTP administered after MV, which had MRR 14.83 (1.88-117.1), test of interaction P = .011. Compared with having DTP (no MV) as most recent vaccination, MV-only had a nonaccident MRR of 0.56 (0.32-0.99). CONCLUSION: The negative effects of non-live DTP with or after live MV are not explained merely by selection bias. These observations support a live-vaccine-last policy where DTP should not be given with or after MV.
BACKGROUND: Due to delays in vaccinations, diphtheria-tetanus-whole-cell-pertussis (DTP) is often given with or after measles vaccine (MV)-out of sequence. We reanalyzed data from Matlab, Bangladesh, to examine how administration of MV and DTP out-of-sequence was associated with child survival. METHODS: In sum, 36 650 children born between 1986 and 1999 were followed with registration of vaccinations and survival. Controlling for background factors using Cox proportional hazards models, survival was analyzed between 9 and 24 months of age. We measured the mortality rate ratio (MRR) to compare vaccination groups. Oral polio vaccine (OPV) campaigns, which started in 1995, reduced the mortality rate and reduced the difference between vaccination groups. In the main analysis, we therefore censored for OPV campaigns; there were 151 nonaccident deaths before the OPV campaigns. RESULTS: Compared with MV administered alone (MV-only), DTP administered with or after MV had MRR 2.20 (1.31-3.70), and DTP-only had MRR 1.78 (1.01-3.11). Compared with MV-only, DTP administered with MV had a female-male MRR 0.56 (0.13-2.38), significantly different to DTP administered after MV, which had MRR 14.83 (1.88-117.1), test of interaction P = .011. Compared with having DTP (no MV) as most recent vaccination, MV-only had a nonaccident MRR of 0.56 (0.32-0.99). CONCLUSION: The negative effects of non-live DTP with or after live MV are not explained merely by selection bias. These observations support a live-vaccine-last policy where DTP should not be given with or after MV.
Authors: Syed Manzoor Ahmed Hanifi; Sofie Biering-Sørensen; Aksel Karl Georg Jensen; Peter Aaby; Abbas Bhuiya Journal: Hum Vaccin Immunother Date: 2020-06-23 Impact factor: 3.452
Authors: Joann Diray-Arce; Asimenia Angelidou; Kristoffer Jarlov Jensen; Maria Giulia Conti; Rachel S Kelly; Matthew A Pettengill; Mark Liu; Simon D van Haren; Scott D McCulloch; Greg Michelloti; Olubukola Idoko; Tobias R Kollmann; Beate Kampmann; Hanno Steen; Al Ozonoff; Jessica Lasky-Su; Christine S Benn; Ofer Levy Journal: Cell Rep Date: 2022-05-03 Impact factor: 9.995
Authors: Peter Aaby; Sebastian Nielsen; Ane B Fisker; Line M Pedersen; Paul Welaga; Syed M A Hanifi; Cesario L Martins; Amabelia Rodrigues; Konstantin Chumakov; Christine S Benn Journal: Open Forum Infect Dis Date: 2022-07-27 Impact factor: 4.423